Terms: = Thyroid cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Treatment
28 results:
1. Construction and validation of a prognostic nutritional index-based nomogram for predicting pathological complete response in breast cancer: a two-center study of 1,170 patients.
Qu F; Luo Y; Peng Y; Yu H; Sun L; Liu S; Zeng X
Front Immunol; 2023; 14():1335546. PubMed ID: 38274836
[TBL] [Abstract] [Full Text] [Related]
2. Therapeutic inhibition of atr in differentiated thyroid cancer.
Lin SF; Lee YY; Wu MH; Lu YL; Yeh CN; Chen WY; Chou TC; Wong RJ
Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37902083
[TBL] [Abstract] [Full Text] [Related]
3. [Efficacy and safety of Anlotinib in the treatment of advanced sarcoma].
Yan Q; Yao WT; Du XH; Guo LY; Fan YC
Zhonghua Zhong Liu Za Zhi; 2023 Oct; 45(10):904-910. PubMed ID: 37875427
[No Abstract] [Full Text] [Related]
4. Endoscopic hemithyroidectomy plus prophylactic central neck dissection via breast approach versus gasless transaxillary approach in treating low-risk papillary thyroid cancer: a retrospective series.
Zhang X; Hu XJ; Hua KJ
Updates Surg; 2023 Apr; 75(3):707-715. PubMed ID: 36848003
[TBL] [Abstract] [Full Text] [Related]
5. thyroid dysfunction in Chinese nasopharyngeal carcinoma after anti-PD-1 therapy and its association with treatment response.
Chen ZH; Zheng WH; Wu CF; Kou J; Yang XL; Lin L; Lv JW; Sun Y; Zhou GQ
BMC Med; 2023 Jan; 21(1):18. PubMed ID: 36647058
[TBL] [Abstract] [Full Text] [Related]
6. Predictive Factors for Bilateral Disease in Papillary Microcarcinoma: A Retrospective Cohort Study.
Lindner K; Iwen KA; Kußmann J; Fendrich V
Curr Oncol; 2022 Aug; 29(9):6010-6017. PubMed ID: 36135042
[TBL] [Abstract] [Full Text] [Related]
7. Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors.
Gao T; Zhao L; Zhang F; Cao C; Fan S; Shi X
World J Surg Oncol; 2022 Jun; 20(1):207. PubMed ID: 35710427
[TBL] [Abstract] [Full Text] [Related]
8. LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p/MTDH pathway-mediated autophagy and genomic instability.
Li PP; Li RG; Huang YQ; Lu JP; Zhang WJ; Wang ZY
Aging (Albany NY); 2021 Nov; 13(21):24171-24191. PubMed ID: 34740994
[TBL] [Abstract] [Full Text] [Related]
9. Expression of epithelial membrane protein (EMP) 1, EMP 2, and EMP 3 in thyroid cancer.
Kim EK; Koo JS
Histol Histopathol; 2022 Jan; 37(1):51-61. PubMed ID: 34617578
[TBL] [Abstract] [Full Text] [Related]
10. Circular RNA Circ_0067934 Attenuates Ferroptosis of thyroid cancer Cells by miR-545-3p/SLC7A11 Signaling.
Wang HH; Ma JN; Zhan XR
Front Endocrinol (Lausanne); 2021; 12():670031. PubMed ID: 34290668
[TBL] [Abstract] [Full Text] [Related]
11. Extracranial dose and the risk of radiation-induced malignancy after intracranial stereotactic radiosurgery: is it time to establish a therapeutic reference level?
Paddick I; Cameron A; Dimitriadis A
Acta Neurochir (Wien); 2021 Apr; 163(4):971-979. PubMed ID: 33325003
[TBL] [Abstract] [Full Text] [Related]
12. Diallyl trisulfide induces G2/M cell-cycle arrest and apoptosis in anaplastic thyroid carcinoma 8505C cells.
Zheng J; Cheng X; Xu S; Zhang L; Pan J; Yu H; Bao J; Lu R
Food Funct; 2019 Nov; 10(11):7253-7261. PubMed ID: 31617531
[TBL] [Abstract] [Full Text] [Related]
13. Laser Ablation of Benign thyroid Nodules: A Prospective Pilot Study With a Preliminary Analysis of the Employed Energy.
de Freitas RMC; Miazaki AP; Tsunemi MH; de Araujo Filho VJF; Marui S; Danilovic DLS; Buchpiguel CA; Chammas MC
Lasers Surg Med; 2020 Apr; 52(4):323-332. PubMed ID: 31347193
[TBL] [Abstract] [Full Text] [Related]
14. Punicalagin from pomegranate promotes human papillary thyroid carcinoma BCPAP cell death by triggering ATM-mediated DNA damage response.
Yao X; Cheng X; Zhang L; Yu H; Bao J; Guan H; Lu R
Nutr Res; 2017 Nov; 47():63-71. PubMed ID: 29241579
[TBL] [Abstract] [Full Text] [Related]
15. Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer.
Xiang S; Xiang T; Xiao Q; Li Y; Shao B; Luo T
Int J Oncol; 2017 Sep; 51(3):801-811. PubMed ID: 28677721
[TBL] [Abstract] [Full Text] [Related]
16. Trends and Patterns of Disparities in cancer Mortality Among US Counties, 1980-2014.
Mokdad AH; Dwyer-Lindgren L; Fitzmaurice C; Stubbs RW; Bertozzi-Villa A; Morozoff C; Charara R; Allen C; Naghavi M; Murray CJ
JAMA; 2017 Jan; 317(4):388-406. PubMed ID: 28118455
[TBL] [Abstract] [Full Text] [Related]
17. Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas.
Burrows N; Williams J; Telfer BA; Resch J; Valentine HR; Fitzmaurice RJ; Eustace A; Irlam J; Rowling EJ; Hoang-Vu C; West CM; Brabant G; Williams KJ
Oncotarget; 2016 Sep; 7(39):63106-63123. PubMed ID: 27527858
[TBL] [Abstract] [Full Text] [Related]
18. Differential Clinicopathological Risk and Prognosis of Major Papillary thyroid cancer Variants.
Shi X; Liu R; Basolo F; Giannini R; Shen X; Teng D; Guan H; Shan Z; Teng W; Musholt TJ; Al-Kuraya K; Fugazzola L; Colombo C; Kebebew E; Jarzab B; Czarniecka A; Bendlova B; Sykorova V; Sobrinho-Simões M; Soares P; Shong YK; Kim TY; Cheng S; Asa SL; Viola D; Elisei R; Yip L; Mian C; Vianello F; Wang Y; Zhao S; Oler G; Cerutti JM; Puxeddu E; Qu S; Wei Q; Xu H; O'Neill CJ; Sywak MS; Clifton-Bligh R; Lam AK; Riesco-Eizaguirre G; Santisteban P; Yu H; Tallini G; Holt EH; Vasko V; Xing M
J Clin Endocrinol Metab; 2016 Jan; 101(1):264-74. PubMed ID: 26529630
[TBL] [Abstract] [Full Text] [Related]
19. Induction of ROS-independent DNA damage by curcumin leads to G2/M cell cycle arrest and apoptosis in human papillary thyroid carcinoma BCPAP cells.
Zhang L; Cheng X; Gao Y; Bao J; Guan H; Lu R; Yu H; Xu Q; Sun Y
Food Funct; 2016 Jan; 7(1):315-25. PubMed ID: 26442630
[TBL] [Abstract] [Full Text] [Related]
20. Novel heat shock protein 90 inhibitor NVP-AUY922 synergizes with the histone deacetylase inhibitor PXD101 in induction of death of anaplastic thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
J Clin Endocrinol Metab; 2015 Feb; 100(2):E253-61. PubMed ID: 25389633
[TBL] [Abstract] [Full Text] [Related]
[Next]
